Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Feb, 2017 | Pages:
100 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global autoimmune disease diagnostics market is expected to reach a value of USD 5.0 billion by 2025, based on a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases. Moreover, presence of favorable government initiatives aimed at curbing incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period. Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results. Further Key Findings from the Study Suggest: Localized autoimmune disease diagnostics was the largest segment in 2015 owing to high usage for type 1 diabetes and idiopathic thrombocytopenic purpura Type 1 diabetes is estimated to grow at a significant growth rate of over 4.0% in localized disease type segment Systemic disease diagnostics is anticipated to witness lucrative CAGR of around 5.0% over the forecast period due to increasing R&D for the development of novel diagnostic biomarkers for the treatment of rheumatoid arthritis and systemic lupus erythematosus Rheumatoid arthritis is one of the most recurring autoimmune disorders further demanding high amount of rapid diagnostics for exploring better alternative treatments North America was the largest regional market in 2015. High market penetration rate of technologically advanced products and increased lab automation rate are some of the factors contributing to its large share Asia Pacific region is anticipated to grow at the fastest CAGR of above 4.0% over the forecast period owing to increasing focus on type 1 diabetes diagnosis Some of the key players of this market include F. Hoffmann-La Roche Ltd; Siemens Healthineers; Abbott Laboratories; Beckman Coulter, Inc.; SQI Diagnostics; Quest Diagnostics; EUROIMMUN AG; AESKU. Diagnostics; Inova Diagnostics, Inc.; Crescendo Bioscience, Inc.; bioMerieux SA; Bio-Rad Laboratories, Inc.; and Hemagen Diagnostics, Inc.
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR's internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Autoimmune Disease Diagnostics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Presence of research funding programs
3.1.1.2 Presence of favorable government initiatives
3.1.1.3 Growing patient awareness levels
3.1.1.4 Technological innovation in the form of lab automation
3.1.2 Market restraint analysis
3.1.2.1 Slow diagnostic result turnaround times and lack of skilled healthcare practitioners
3.2 Penetration & Growth Prospect Mapping
3.3 Autoimmune Disease Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's
Chapter 4 Autoimmune Disease Diagnostics: Type Estimates & Trend Analysis
4.1 Autoimmune Disease Diagnostics Market: Type Movement Analysis
4.2 Systemic Autoimmune Disease Diagnostics
4.2.1 Systemic autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
4.2.2 Rheumatoid arthritis diagnostics
4.2.2.1 Rheumatoid arthritis diagnostics market, 2013 - 2025 (USD Million)
4.2.3 Ankylosing spondylitis diagnostics
4.2.3.1 Ankylosing spondylitis diagnostics market, 2013 - 2025 (USD Million)
4.2.4 Systemic lupus erythematosus (SLE) diagnostics
4.2.4.1 Systemic lupus erythematosus (SLE) diagnostics market, 2013 - 2025 (USD Million)
4.2.5 Other systemic autoimmune disease diagnostics
4.2.5.1 Other systemic autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
4.3 Localized Disease Diagnostics
4.3.1 Localized disease diagnostics market, 2013 - 2025 (USD Million)
4.3.2 Multiple sclerosis diagnostics
4.3.2.1 Multiple sclerosis diagnostics market, 2013 - 2025 (USD Million)
4.3.3 Type 1 diabetes diagnostics
4.3.3.1 Type 1 diabetes diagnostics market, 2013 - 2025 (USD Million)
4.3.4 Hashimoto's Thyroiditis diagnostics
4.3.4.1 Hashimoto's Thyroiditis diagnostics market, 2013 - 2025 (USD Million)
4.3.5 Idiopathic Thrombocytopenic Purpura (ITP) diagnostics
4.3.5.1 Idiopathic thrombocytopenic purpura diagnostics market, 2013 - 2025 (USD Million)
4.3.6 Other localized autoimmune disease diagnostics
4.3.6.1 Other diagnostics market, 2013 - 2025 (USD Million)
Chapter 5 Autoimmune Disease Diagnostics: Regional Estimates & Trend Analysis, by Type
5.1 Autoimmune Disease Diagnostics Market Share, By Region, 2013 & 2020
5.2 North America
5.2.1 U.S.
5.2.1.1 U.S autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.2.2 Canada
5.2.2.1 Canada autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.3.2 UK
5.3.2.1 UK autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.3.3 Germany
5.3.3.1 Germany autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.4.2 Japan
5.4.2.1 Japan autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.4.3 China
5.4.3.1 China autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.4.4 India
5.4.4.1 India autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.5 Latin America
5.5.1 Latin America autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico autoimmune disease diagnostics market, 2013 - 2025 (USD Million)
5.6 MEA
5.6.1 MEA autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa autoimmune disease diagnostics market, 2013 - 2024 (USD Million)
Chapter 6 Competitive Landscape
6.1 Market Participation Categorization
6.2 Company Profiles
6.2.1 Abbott Laboratories
6.2.1.1 Company overview
6.2.1.2 Financial performance
6.2.1.3 Product benchmarking
6.2.1.4 Strategic initiatives
6.2.2 Siemens Healthineers
6.2.2.1 Company overview
6.2.2.2 Product benchmarking
6.2.2.3 Strategic initiatives
6.2.3 Roche Diagnostics
6.2.3.1 Company overview
6.2.3.2 Product benchmarking
6.2.3.3 Strategic initiatives
6.2.4 Beckman Coulter, Inc.
6.2.4.1 Company overview
6.2.4.2 Product benchmarking
6.2.5 SQI Diagnostics, Inc.
6.2.5.1 Company overview
6.2.5.2 Product benchmarking
6.2.5.3 Strategic initiatives
6.2.6 EUROIMMUN AG
6.2.6.1 Company overview
6.2.6.2 Product benchmarking
6.2.6.3 Strategic initiatives
6.2.7 AESKU.Diagnostics GmbH & Co. KG
6.2.7.1 Company overview
6.2.7.2 Product benchmarking
6.2.7.3 Strategic initiatives
6.2.8 Inova Diagnostics
6.2.8.1 Company overview
6.2.8.2 Product benchmarking
6.2.8.3 Strategic initiatives
6.2.9 Crescendo Bioscience, Inc.
6.2.9.1 Company overview
6.2.9.2 Product benchmarking
6.2.9.3 Strategic initiatives
6.2.10 bioMerieux SA
6.2.10.1 Company overview
6.2.10.2 Financial performance
6.2.10.3 Product benchmarking
6.2.10.4 Strategic initiatives
6.2.11 Bio-Rad Laboratories, Inc.
6.2.11.1 Company overview
6.2.11.2 Financial performance
6.2.11.3 Product benchmarking
6.2.11.4 Strategic initiatives
6.2.12 Hemagen Diagnostics, Inc.
6.2.12.1 Company overview
6.2.12.2 Product benchmarking
6.2.13 Quest Diagnostics
6.2.13.1 Company overview
6.2.13.2 Financial performance
6.2.13.3 Product benchmarking
6.2.13.4 Strategic initiatives
List of Tables TABLE 1 Country share estimation TABLE 2 List of NIH funding programs, 2013 TABLE 3 Potential biomarkers and their potential applications in treating SLE TABLE 4 ITP prevalence, by condition TABLE 5 North America autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 6 North America systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 7 North America localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 8 U.S. autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 9 U.S. systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 10 U.S. localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 11 Canada autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 12 Canada systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 13 Canada localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 14 Europe autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 15 Europe systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 16 Europe localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 17 UK autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 18 UK systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 19 UK localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 20 Germany autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 21 Germany systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 22 Germany localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 23 Asia Pacific autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 24 Asia Pacific systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 25 Asia Pacific localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 26 Japan autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 27 Japan systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 28 Japan localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 29 China autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 30 China systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 31 China localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 32 India autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 33 India systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 34 India localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 35 Latin America autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 36 Latin America systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 37 Latin America localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 38 Brazil autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 39 Brazil systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 40 Brazil localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 41 Mexico autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 42 Mexico systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 43 Mexico localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 44 MEA autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 45 MEA systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 46 MEA localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 47 South Africa autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 48 South Africa systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE 49 South Africa localized autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
